CZL-S092
CZL-S092 is a PLK4 inhibitor with exceptional selectivity for other PLK4 family members (PLK1, PLK2, and PLK3), exhibiting an IC50 of 0.9 nM. It demonstrates antineuroblastoma activity in vitro (IMR-32, IC50 = 1.143 μM) and shows good oral bioavailability in vivo (SD rats, F = 22.1%) . CZL-S092 is applicable in research on various cancers, including neuroblastoma.
Product Specifications
Field of Research
Cell Biology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1858805 3x 1.0 µg
RNU7-43P sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details FY-AB34391-01 1 mL
Anti-Selectin, Leukocyte (SELL) Polyclonal antibody
Sign In for Pricing
View Details FY-AB34391-02 100 µL
Anti-Selectin, Leukocyte (SELL) Polyclonal antibody
Sign In for Pricing
View Details FY-AB34391-03 200 µL
Anti-Selectin, Leukocyte (SELL) Polyclonal antibody
Sign In for Pricing
View Details RPU60093-01 50 µg
Prokaryotic Mouse Immune Receptor Expressed On Myeloid Cells 1
Sign In for Pricing
View Details RPU60093-02 100 µg
Prokaryotic Mouse Immune Receptor Expressed On Myeloid Cells 1
Sign In for Pricing
View Details